BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
38 hedge funds and large institutions have $2.52M invested in BRAINSTORM CELL THERAPUTC in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
38
Holding in Top 10
–
Calls
$42K
Puts
$29K
Top Buyers
| 1 | +$44.2K | |
| 2 | +$12.2K | |
| 3 | +$5.52K | |
| 4 |
Morgan Stanley
New York
|
+$2.88K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
+$2.53K |
Top Sellers
| 1 | -$235K | |
| 2 | -$30.5K | |
| 3 | -$18.9K | |
| 4 |
VF
Virtu Financial
New York
|
-$17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.5K |